{"nct_id":"NCT00617669","title":"A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer","status":"COMPLETED","status_verified_date":"2012-04","start_date":"2008-01","start_date_type":null,"primary_completion_date":"2011-05","primary_completion_date_type":"ACTUAL","completion_date":"2011-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AZN"]}